3
Preparation
of
(R)-3-hydroxy-1-((S)-4-isopropyl-2-
Procedure
B:
Preparation
of
(R)-3-phenyl-3-
thioxothiazolidin-3-yl)-3-phenylpropan-1-one (7): To a pre-
cooled (−15 °C) solution of 6 (0.4 g, 2 mmol) in freshly distilled
dry CH2Cl2 (8 mL) was added diisopropylethylamine (0.45 mL,
2.6 mmol) under inert atmosphere. TiCl4 (0.24 mL, 2.2 mmol)
was introduced into the reaction mixture and the resulting dark
brown solution was stirred for 30 min at −15 °C. The reaction
mixture was cooled to −78 °C and a solution of benzaldehyde
(0.2 mL, 2.1 mmol) in CH2Cl2 (4 mL) was added dropwise and
was stirred at −78 °C. After completion of the reaction (~30
min), it was quenched by addition of saturated NH4Cl solution
(10 mL). The reaction mixture was extracted with CH2Cl2 (2 x 10
mL). The combined organic layers were washed with brine (10
mL) and dried over anhydrous Na2SO4. Evaporation of the
solvent followed by silica gel column chromatography of the
resultant residue with petroleum ether/EtOAc (8:2) as eluent
furnished 7 (0.47 g, 77%) as yellow colour oil and 7a (0.036 g,
((triethylsilyl)oxy)propanal (4): To a solution of the compound
8 (0.28 g, 0.6 mmol) in CH2Cl2 (7 mL) was added DIBAL-H (1.3
mL, 1.3 mmol) at −78 °C and was stirred at the same temperature
for 10 min. After the reaction was complete (TLC), it as
quenched by addition of aqueous saturated solution of sodium
potassium tartrate (10 mL) and allowed to stir at room
temperature for 1 h. The reaction mixture was then extracted with
EtOAc (2 × 20 mL) and the combined organic extract was
washed with brine (10 mL), dried over anhydrous Na2SO4.
Evaporation of the solvent gave the crude residue which on
purification using silica gel column chromatography, petroleum
ether/EtOAc (9:1) as eluent afforded the aldehyde 4 (0.13 g,
75%) as a colourless oil; [α]24 +74.4 (c 2.2, CHCl3); IR (neat)
D
2954, 2877, 2724, 1721, 1666 cm-1; 1H NMR (400 MHz, CDCl3)
δ 9.78 (t, J = 2.4 Hz, 1H), 7.37-7.22 (m, 5H), 5.22 (dd, J = 8.0,
4.4 Hz, 1H), 2.87 (ddd, J = 15.6, 8.0, 2.4 Hz, 1H), 2.64 (ddd, J =
15.6, 4.0, 2.0 Hz, 1H), 0.86 (t, J = 8.0 Hz, 9H), 0.53 (ddd, J =
15.2, 7.6, 2.0 Hz, 6H); 13C NMR (100 MHz, CDCl3) 201.4,
143.8, 128.4 (2C), 127.6, 125.6 (2C), 70.5, 53.9, 6.6 (3C), 4.7
(3C); HRMS for C15H24O2Si+Na calcd 287.1443; found
287.1445.
6%) as yellow colour solid; Major diastereomer 7: [α]24
D
+353.5 (c 1.1, CHCl3), [lit3 [α]24 +386.7 (c 1.0, CHCl3)]; IR
D
(neat) 3419, 2921, 1694, 1514, 1161 cm-1; H NMR (400 MHz,
1
CDCl3) δ 7.43-7.25 (m, 5H), 5.27 (dd, J = 9.2, 2.8 Hz, 1H), 5.13
(t, J = 7.2 Hz, 1H), 3.79 (dd, J = 17.2, 2.4 Hz, 1H), 3.59 (dd, J =
17.2, 9.2 Hz, 1H), 3.48 (dd, J = 11.6, 8 Hz, 1H), 3.02 (d, J = 11.6
Hz, 1H), 2.37 (sext, J = 6.8 Hz, 1H), 1.06 (d, J = 6.8 Hz, 3H),
0.99 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.0,
172.6, 142.4, 128.5 (2C), 127.7, 125.8 (2C), 71.5, 70.2, 46.8,
30.8, 30.7, 19.1, 17.8; HRMS for C15H19NO2S2+Na calcd
332.0755; found 332.0765.
Preparation of (R)-1-((S)-4-isopropyl-2-thioxothiazolidin-3-
yl)-3-phenyl-3-((trimethylsilyl)oxy)propan-1-one (8a): TMS-
ether 8a was prepared from the alcohol 7 (0.09 g, 0.32 mmol)
with diisopropylethylamine (0.08 mL, 0.5 mmol) in presence of
trimethylsilyltriflate (0.06 mL, 0.36 mmol) using the procedure A
described above in (0.09 g, 81%) as a yellow oil; [α]24D +350.7 (c
1
1.0, CHCl3); IR (neat) 2960, 2736, 1697, 1598, 1460 cm-1; H
Minor diastereomer 7a: (S)-3-hydroxy-1-((S)-4-isopropyl-2-
thioxothiazolidin-3-yl)-3-phenylpropan-1-one: M.P: 86–90 °C,
[lit.3 M.P: 88–95 °C]; [α]24 +271.7 (c 1.1, CHCl3), [lit3 [α]24
NMR (400 MHz, CDCl3) δ 7.39-7.21 (m, 5H), 5.32 (dd, J = 9.2,
3.2 Hz, 1H), 5.04 (t, J = 7.2 Hz, 1H), 3.86 (dd, J = 16.4, 9.2 Hz,
1H), 3.49 (dd, J = 11.6, 8.0 Hz, 1H), 3.30 (dd, J = 16.4, 3.2 Hz,
1H), 3.02 (d, J = 11.2 Hz, 1H), 2.35 (sext, J = 6.8 Hz, 1H), 1.03
(d, J = 6.8 Hz, 3H), 0.96 (d, J = 7.2 Hz, 3H), 0.02 (s, 9H); 13C
NMR (100 MHz, CDCl3) δ 202.7, 171.1, 143.9, 128.3 (2C),
127.4, 126.0 (2C), 71.7 (2C), 48.4, 30.9, 30.8, 19.1, 17.7, 0.1
(3C); HRMS for C18H27NO2SiS2+Na calcd 404.1150; found
404.1151.
D
D
+279.2 (c 1.0, CHCl3)].; IR (KBr) 3423, 2962, 1689, 1493, 1159
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.45-7.20 (m, 5H), 5.21-5.11
(m, 2H), 3.83 (dd, J = 17.2, 9.6 Hz, 1H), 3.59 (dd, J = 17.2, 3.2
Hz, 1H), 3.48 (dd, J = 11.6, 8.0 Hz, 1H), 3.02 (d, J = 11.2 Hz,
1H), 2.36 (sext, J = 6.8 Hz, 1H), 1.06 (d, J = 6.8 Hz, 3H), 0.98
(d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 203.0, 172.9,
142.4, 128.5 (2C), 127.7, 125.9 (2C), 71.4, 70.7, 46.7, 30.7, 30.6,
19.0, 17.7; HRMS for C15H19NO2S2+Na calcd 332.0755; found
332.0757.
Preparation of (R)-3-phenyl-3-((trimethylsilyl)oxy)propanal
4a: aldehyde 4a was prepared from silyl ether 8a (0.09 g,
0.24mmol) in presence of DIBAL-H (0.5 mL, 0.49 mmol) using
the procedure B described above in (0.051 g, 98%) as a colorless
Procedure A: Preparation of (R)-1-((S)-4-isopropyl-2-
thioxothiazolidin-3-yl)-3-phenyl-3-((triethylsilyl)oxy)propan-
1-one (8): To a pre-cooled (−20 °C) solution of 7 (0.35 g, 1.1
mmol) in CH2Cl2 (10 mL) were added diisopropylamine (0.3 mL,
1.7 mmol) and triethylsilyltriflate (0.28 mL, 1.2 mmol). The
reaction mixture was allowed to stir at −20 °C for 0.5 h. After
completion of the reaction (TLC) it was quenched by addition of
water (10 mL) and the reaction mixture was extracted with
EtOAc (2 × 10 mL). The organic layer was washed with brine
(20 mL) dried over anhydrous Na2SO4 and the solvent was
evaporated under reduced pressure to give a crude residue, which
on purification by silica gel column chromatography petroleum
ether/EtOAc (9:1) as eluent furnished the compound 8 (0.35 g,
oil. [α]24 +88.4 (c 0.45, CHCl3); IR (neat) 2960, 2872, 2723,
D
1
1724, 1494 cm-1; H NMR (400 MHz, CDCl3) δ 9.78 (t, J = 2.0
Hz, 1H), 7.37-7.24 (m, 5H), 5.22 (dd, J = 8.4, 4.0 Hz, 1H), 2.88
(ddd, J = 16.0, 8.8, 2.8 Hz, 1H), 2.63 (ddd, J = 16.0, 4.0, 1.6 Hz,
1H), 0.04 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 201.3, 143.6,
128.5 (2C), 127.6, 125.6 (2C), 70.3, 53.8, −0.01 (3C). HRMS for
C12H18O2Si+Na calcd 245.0974; found 245.0977.
Preparation of (R)-3-((tert-butyldimethylsilyl)oxy)-1-((S)-4-
isopropyl-2-thioxothiazolidin-3-yl)-3-phenylpropan-1-one
(8b): TBS-ether 8b was prepared from the alcohol 7 (0.106 g,
0.25 mmol) with diisopropylethylamine (0.08 mL, 0.5 mmol) in
presence of tertiarybutyldimethylsilyltriflate (0.08 mL, 0.35
mmol) using the procedure A described above in (0.106 g, 77%)
73%) as a yellow oil; [α]24 +280.9 (c 1.1, CHCl3); IR (neat)
D
2959, 2854, 1697, 1252, 1151 cm-1; 1H NMR (400 MHz, CDCl3)
δ 7.38-7.21 (m, 5H), 5.31 (dd, J = 8.8, 3.6 Hz, 1H), 5.02 (t, J =
6.8 Hz, 1H), 3.96 (dd, J = 16.4, 8.8 Hz, 1H), 3.47 (dd, J = 11.6,
8.0 Hz, 1H), 3.21 (dd, J = 16.4, 3.6 Hz, 1H), 3.02 (d, J = 11.6 Hz,
1H), 2.34 (sextet, J = 13.6, 6.8 Hz, 1H), 1.02 (d, J = 6.8 Hz, 3H),
0.94 (d, J = 7.2 Hz, 3H), 0.84 (t, J = 8.0 Hz, 9H), 0.56-0.44 (m,
6H); 13C NMR (100 MHz, CDCl3) δ 202.8, 171.2, 144.1, 128.2
(2C), 127.5, 126.1 (2C), 71.8, 71.7, 48.5, 30.9, 30.8, 19.1, 17.8,
6.7 (3C), 4.7 (3C). HRMS for C21H33NO2SiS2+Na calcd
446.1620; found 446.1620.
as a yellow oil. [α]24 +318.3 (c 2.3, CHCl3); IR (neat) 2927,
D
1
2855, 2314, 1695, 1582 cm-1; H NMR (400 MHz, CDCl3) δ
7.38-7.20 (m, 5H), 5.29 (dd, J = 9.2, 3.6 Hz, 1H), 5.01 (t, J = 6.8
Hz, 1H), 3.99 (dd, J = 16.4, 9.2 Hz, 1H), 3.47 (dd, J = 11.2, 8.0
Hz, 1H), 3.16 (dd, J = 16.4, 3.6 Hz, 1H), 3.02 (d, J = 11.2 Hz,
1H), 2.35 (sext, J = 6.8 Hz, 1H), 1.03 (d, J = 6.4 Hz, 3H), 0.95
(d, J = 7.2 Hz, 3H), 0.83 (s, 9H), 0.03 (s, 3H), −0.18 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 202.8, 171.3, 144.0, 128.2 (2C),